All Type of News
Ilyang awaits approval for ilaprazole in China
Ilyang Pharm is soon expecting to receive marketing approval for ilaprazole, a new investigational proton pump inhibitor, from the Chinese drug regulatory agency (SFDA) after completing a local phase III clinical stud...
Hanmi to enhance services for doctors and pharmacists.Hanmi signed an MOU with Daeshin Security company for a joint marketing service to be rendered to doctors and pharmacists on Aug. 8.
Hanmi said "To boost a customer relation...
|
Multinational drug makers to face FTC scrutiny
Foreign-invested pharmaceutical firms will come under the scrutiny of the Fair Trade Commission as the Ministry of Health and Welfare has recently requested the FTC to demand these firms' unfair business code.
In a...
NHI payment possibility for anti-obesity medications attracts keen interests.
On July 25 the Seoul District Administrative Court decided that the anti-obesity medication should be deemed as an eligible subject to include the NHI reimbursement scheme unless the treatment was purported for an aes...
Pfizer Korea to hire 20 CRAs
Pfizer Korea said on August 8 that it plans to begin its official recruitment of 20 clinical research associates (CRAs) until August 24, as part of its efforts to substantiate its prior commitment to invest $300 milli...
Pharmacy advertising inside hospitals regarded as illegal business collusion.
The advertising of pharmacy inside any medical clinic or hospital covering the pharmacy location or contact informations or signs shall be regarded as a business collusion between the subjected pharmacy and the hospit...
One in every 5 teenagers is smoking, KCDC says
One out of every five 18-year olds is smoking, the Korea Centers for Disease Control and Prevention said on August 6.
The finding was made public in an online survey of 80,000 teenagers ranging from middle school f...
Multinational drug manufacturers trim production in Korea
Foreign drug makers reduced production in Korea as the nation's major players like GlaxoSmithKline, Roche Korea and Wyeth Korea left the country to find better sites for their plants abroad.
According to ...
Multinational drug corporations now put major efforts for anticancer markets in Korea.
Major multinational drug corporations have not shown any intensive efforts for the anti-cancer drug markets but recently, GSK, for instance, has declared major promotional
activities initially by taking an occasion o...
Lilly Korea says KFDA approved Cymbalta, new anti-depressant.
Lilly Korea announced that the KFDA approved Cymbalta (duloxetine HCL), a new generation of anti-depressant drug, on July 30 for the treatment of major depressive disorders (MDD)
Cymbalta is an SNRI anti-depress...
